DPP4 and prediabetes syndrome: Gal-4 facilitates the transport of dipeptidyl peptidase-4 (DPP-4) to the intestinal epithelium, leading to decreased incretin activity and contributing to impaired insulin secretion, prediabetes and its cardiometabolic complications.